William S. Gilmer, MD; | Psychiatrist.com

Clinical Outcomes of IV Ketamine for Depression

Original Research

Clinical Outcomes of IV Ketamine for Depression

January 8, 2024

Short-term clinical trials found intravenous (IV) ketamine to be effective in reducing depressive symptoms. This study assessed longer-term outcomes of IV ketamine for depression and explored treatment and patient...

Paul N. Pfeiffer , Jamarie Geller , Dara Ganoczy , et al

Original Research

Quantitative Electroencephalogram Biomarkers for Predicting Likelihood and Speed of Achieving Sustained Remission in Major Depression: A Report From the Biomarkers for Rapid Identification of Treatment Effectiveness in Major Depression (BRITE-MD) Trial

January 15, 2013

Ian A. Cook , Aimee M. Hunter , William S. Gilmer , et al

Original Research

Does the Duration of Index Episode Affect the Treatment Outcome of Major Depressive Disorder? A STAR*D Report

August 31, 2008

William S. Gilmer , Jackie K. Gollan , Stephen R. Wisniewski , et al

Original Research

Divalproex in the Treatment of Acute Bipolar Depression: A Preliminary Double-Blind, Randomized, Placebo-Controlled Pilot Study

December 14, 2007

S. Nassir Ghaemi , William S. Gilmer , Joseph F. Goldberg , et al

Original Research

Human Immunodeficiency Virus and Depression in Primary Care: A Clinical Review

August 15, 2006

Tiziano Colibazzi , Teresa T. Hsu , William S. Gilmer